Key Takeaways for Pharmacists
- Small, achievable plant-based substitutions—rather than full dietary overhauls—can drive sustainable improvements in weight and glycemic control.
- Addressing common barriers such as taste, cost, and convenience helps patients adopt plant-based eating patterns more successfully.
- Framing diet as a complement to medications reinforces adherence, enhances treatment effectiveness, and supports long-term cardiometabolic risk reduction.
Pharmacy Times: What are common barriers patients face when trying to adopt more plant-based eating patterns, and what practical strategies can pharmacists offer to help overcome these obstacles?
Kahleova: Common barriers include concerns about taste, cost, convenience, and family acceptance. Many patients worry that plant-based eating will require unfamiliar foods or extensive cooking. Pharmacists can reassure patients that plant-based eating does not have to be complicated. Familiar foods—such as pasta, sandwiches, cereals, soups, and stir-fries—can easily be made plant-based. Encouraging patients to involve family members in meal planning and to explore restaurants with plant-based options can also improve adherence.
Community support can be helpful as well. Patients may benefit from local or online plant-based groups, cooking classes, or educational resources that provide recipes and practical guidance.
Pharmacy Times: For patients already on glucose-lowering or lipid-lowering medications, how can pharmacists frame discussions about diet so that dietary changes complement pharmacotherapy and improve outcomes?
Kahleova: Dietary change should be presented as a complement—not a replacement—for medical therapy. Our clinical research shows that adopting a low-fat, plant-based diet can significantly improve cholesterol levels, glycemic control, and body weight, sometimes allowing medication doses to be reduced under physician supervision. Pharmacists can explain that medications treat the symptoms of cardiometabolic disease, while diet addresses many of the underlying causes—such as excess saturated fat intake, hepatic fat accumulation, and insulin resistance.
For pharmacists, this distinction is empowering—it allows for practical, patient-centered counseling that prioritizes achievable dietary improvements rather than rigid food rules. - Hana Kahleova, MD, PhD, MBA
By reinforcing that dietary improvements may enhance medication effectiveness and potentially reduce long-term medication burden, pharmacists can motivate patients while emphasizing the importance of ongoing monitoring and collaboration with their health care team.
Pharmacy Times: Is there anything else that you would like to add?
Kahleova: One important message from our review is that public discussions around ultraprocessed foods should not overlook food sources. The evidence consistently shows that ultraprocessed animal foods—especially processed meats and sweetened beverages—are the primary drivers of cardiometabolic harm, while many plant-based ultraprocessed foods are associated with neutral or beneficial outcomes.
For pharmacists, this distinction is empowering. It allows for practical, patient-centered counseling that prioritizes achievable dietary improvements rather than rigid food rules—supporting better long-term adherence and better cardiometabolic health.
REFERENCES
1. Kahleova H, Halpern L. Q&A: why food source matters more than processing in cardiometabolic risk reduction. February 3, 2026. Accessed February 3, 2026. https://www.pharmacytimes.com/view/q-a-why-food-source-matters-more-than-processing-in-cardiometabolic-risk-reduction
2. Kahleova H, Petersen KF, Shulman GI, et al. Effect of a low-fat vegan diet on body weight, insulin sensitivity, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults: a randomized clinical trial. JAMA Netw Open. 2020;3(11):e2025454. doi:10.1001/jamanetworkopen.2020.25454